SPIA
BCRX icon

Steward Partners Investment Advisory’s BioCryst Pharmaceuticals BCRX Stock Holding History

Steward Partners Investment Advisory’s Portfolio BCRX Stock Details BCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-600
Closed -$4.55K – 4325
2025
Q3 		$4.55K Hold
600
– – ﹤0.01% 3686
2025
Q2 		$5.38K Hold
600
– – ﹤0.01% 3454
2025
Q1 		$4.5K Buy
+600
New +$4.84K ﹤0.01% 3407
2022
Q1 		– Sell
-150
Closed -$2K – 3283
2021
Q4 		$2K Buy
+150
New +$1.99K ﹤0.01% 3002
2021
Q2 		– Sell
-1,000
Closed -$10.2K – 7108
2021
Q1 		$10.2K Buy
+1,000
New +$10.3K ﹤0.01% 2777

Other funds holding BCRX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.58B AUM 138.67% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $564B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return